Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
20.85 USD | -0.95% | -3.65% | +86.16% |
24/06 | Harrow, Inc.(NasdaqGM:HROW) added to S&P Pharmaceuticals Select Industry Index | CI |
21/06 | Craig-Hallum Adjusts Price Target on Harrow Health to $30 From $26, Buy Rating Maintained | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+86.16% | 738M | |
+55.55% | 816B | |
+39.22% | 634B | |
-6.83% | 351B | |
+17.15% | 323B | |
+7.09% | 293B | |
+13.42% | 238B | |
+0.90% | 222B | |
+13.44% | 218B | |
+7.87% | 167B |
- Stock Market
- Equities
- HROW Stock
- News Harrow, Inc.
- B. Riley Lowers Harrow's PT to $30 From $45 After Lower-Than-Expected Q3 Results, Reduced Q4 Guidance; Keeps Buy Rating